Related Experiment Videos
[Vascular hyperreactivity to vasopressin in mild essential arterial hypertension]
Insights
Essential hypertension patients show an exaggerated pressor response to arginine vasopressin (AVP) infusion, indicating heightened vascular sensitivity to this hormone. This heightened response is not attributed to baroreceptor reflexes or cardiac output changes.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
Context:
- Essential hypertension is a prevalent cardiovascular condition.
- Arginine vasopressin (AVP) plays a role in blood pressure regulation.
Purpose:
- To investigate the hemodynamic effects of arginine vasopressin (AVP) infusion in patients with essential hypertension compared to normotensive controls.
Summary:
- Hypertensive patients exhibited a significantly greater increase in mean arterial pressure and peripheral vascular resistance upon AVP infusion compared to controls.
- Cardiac index decreased more substantially in hypertensive individuals during AVP infusion.
- The exaggerated pressor response in hypertension is likely due to increased vascular sensitivity to AVP, not baroreceptor reflexes or cardiac output alterations.
Impact:
- Provides insight into the specific vascular mechanisms contributing to elevated blood pressure in essential hypertension.
- Suggests a potential role for AVP in the pathophysiology of hypertension.
- Highlights differences in hemodynamic responses to AVP between hypertensive and normotensive individuals.
Abstract:
The aim of the present study was to evaluate the hemodynamic effects of arginine vasopressin (AVP) infusion in essential hypertension. To this end, 9 hypertensive patients and 10 normotensive controls were evaluated. After one hour rest, AVP was infused at a dosage of 0.5 and 2 ng/(kg/min), in 20 minutes periods. After AVP infusion, mean arterial pressure increased only in hypertensive patients (from 125.8 +/- 7 to 131.8 +/- 7, p less than 0.01 and to 135.6 +/- 6 mmHg, p less than 0.01). Peripheral vascular resistance was significantly increased in both groups during AVP infusion, although the percent increase was higher in hypertensive patients during the last period of infusion (18.3 +/- 10 versus 4.6 +/- 4, p less than 0.05). Cardiac index decreased in both groups during infusion, although this reduction was significantly higher in hypertensive patients than in healthy controls in the last period of infusion (-8.16 +/- 6 versus -1.8 +/- 4%, p less than 0.05). These results confirm that in essential hypertension there is an exaggerated pressor response to AVP infusion, suggesting that it is due to an increased vascular response to this hormone. The compensatory reduction of cardiac output and the inhibition of sympathetic nervous activity mediated through baroreceptor reflexes do not apparently play a role in this pressor response.